Category Archives: Health
Latest From Health
In a hearing held on Thursday to review the Department of Health and Human Services 2017 budget, Senate Finance Committee Chairman Orrin Hatch (R-UT) pressed HHS Secretary Sylvia Burwell on whether or not the Obama Administration is planning to issue an executive order that would allow the government to negotiate drug prices. Read more in the Washington Examiner. Video of Thursday’s hearing can be found on the Senate Finance Committee website.
New York Senator Chuck Schumer joined attendees at the 2016 BIO CEO & Investor Conference this afternoon for a fireside chat, moderated by BIO Chairman Ron Cohen, to discuss current political and public policy issues facing the country and the biopharmaceutical industry. The Senator expressed optimism that progress can be made on a bipartisan basis in a number of areas that will be conducive to investment in medical innovation and the well-paying jobs that such Read More >
Check out today’s Wall Street Journal Editorial, highlighting why you can’t make medical progress by punishing medical advances. The editorial highlight’s how political attacks on the innovation ecosystem undermine the ability to bring important advances to patients. It notes that new initiatives, such as the Administration’s cancer “moonshot,” will be less likely to find success if short-sighted politicians create “investment uncertainty” that will drive away private capital away from the biopharmaceutical sector.” Read more in Read More >
Tomorrow at the Newseum, The Hill will be hosting a live discussion about the transition from volume-based to value-based care. A live webcast will be available for the event, which begins at 8:30 am ET. Last week, Jim Robinson, President of Astellas Pharma US, shared his thoughts in a related op-ed at The Hill. Biopharmaceutical innovation is transforming what it means to be a patient battling some of our most difficult diseases, such as cancer, Read More >
Last Friday in the St. Louis Post-Dispatch, Former Senators Jim Talent and Robert Graham wrote about the growing threat of biological attacks and threats and steps our nation can take to help prepare for them, including some of the recommendations in the report of the Blue Ribbon Study Panel on Biodefense, on which BIO President and CEO Jim Greenwood serves. The first step is to stockpile the medical countermeasures that will be necessary in the Read More >